In order to clarify an alteration in thyroid functions in patients with chronic liver diseases, serum total and free thyroxine (T4, FT4), total and free triiodothyronine (T3, FT3), total reverse T3 (rT3), thyrotropin (TSH), thyroxine-binding globulin (TBG) concentrations, and T3 uptake (T3U) were measured by radioimmunoassays in 53 patients with chronic hepatitis (CH), 24 patients with compensated liver cirrhosis (LC), 17 patients with hepatocellular carcinoma associated with LC (HCC), and 40normal subjects. Serum T4, T3, and rT3 in CH, and serum rT3 in HCC were significantly increased, while serum T4 in LC and serum T3 in HCC were significantly decreased.
of reverse T3 (rT3) (Chopra, 1976) , which is biologically almost inactive, are derived from the conversions of T4 by 5'-and 5-monodeiodinases in the peripheral tissues, respectively.
Therefore, the circulating thyroid hormone concentrations are affected by hepatic disorders. The impediments in the metabolism of thyroid hormones and the changes in circulating thyroxine-binding globulin (TBG) concentrations could be expected in liver diseases. Moreover, it has been reported that there are some abnormalities in the hypothalamic-pituitarythyroid axis in patients with nonthyroidal illness (Borst et al., 1983; Green et al., 1976; Kaptein et al., 1981 Kaptein et al., , 1982 , including liver cirrhosis (Bacci et al., 1982; Carter et al., 1974; Hasselbalch et al., 1981; Maturlo et al., 1980) and malignant disorders (Bacci et al., 1982; Carter et al., 1974) .
Although several reports on the circulating thyroid hormones in chronic liver diseases have been published (Barzilai et al., 1974; Borzio et al., 1983.; Chopra et al., 1974; Gershengorn et al., 1976; Iwasaki et al., 1981; Kabadi and Premachandra, 1983; Kalk et al., 1982; Klachko and Johnson, 1983; Schussler et al., 1978; Wartofsky and Burman, 1982; Yamanaka et al., 1980) , they are not always consistent and there are a few mentions of free thyroid hormones. The present study was carried out to study the circulating thyroid hormones in various chronic liver diseases and to clarify the factors that influence the thyroid hormones, thyrotropin (TSH) and TBG. We also tried to assess whether the patients with chronic liver diseases were euthyroid or not. range, 32-72 yr), 17 patients with hepatocellular carcinoma associated with liver cirrhosis (13 men and 4 women, mean age, 56 yr; range, 39-79 yr) and 40 normal subjects (20 men and 20 women, mean age, 40 yr; range, 14-77 yr) were studied. The diagnosis of chronic hepatitis (CH) and compensated liver cirrhosis (LC) were established by liver function tests and in the majority of patients by laparoscopy and liver biopsy, and the diagnosis of hepatocellular carcinoma associated with LC (HCC) was made by liver function tests including a-fetoprotein (AFP) and by imaging diagnostic techniques such as echography, computed tomography an hepatic angiography, and/or by surgery or autopsy. Fifty-three patients with CH included 16 with chronic hepatitis B (CH-B) and 37 with chronic non-A, non-B hepatitis (CH-NANB). Twenty-four of them included 19 with chronic active hepatitis (CAR) and 5 with chronic inactive hepatitis (CIH). None of the patients or normal subjects were complicated with thyroid diseases, nor had they received any drugs which could be thought to affect circulating thyroid hormones.
Serum thyroxine (T4), 3, 5, 3'-triiodothyronine (T3), 3, 3', 5'-trriiodothyonine (reverse T3, rT3) and thyrotropin (TSH) were measured with T4-RIA, T3-RIA, rT3-RIA kits, and a TSH-RIA kit (nonultrasensitive type), and T3 uptake (T3U) with a Triosorb S kit from Dainabot Radioisotope Laboratory, Tokyo, Japan. Serum thyroxine-binding globulin (TBG) concentrations were determined with a RIA-gnost TBG kit from Hoechst, Japan, Ltd.
Free T4 index (FT4I) were calculated as the products of the serum T4 concentration and the values for T3U, and free T3 index (FT3I) were also calculated as the products of the serum T3 concentration and the values for T3U. The T4/TBG ratios and T3/TBG ratios were also calculated.
In 38 of the CH, 19 of the LC, 13 of the HCC, and 30 of the normal subjects, serum free T4 (FT4) and free T3 (FT3) 
Results
Results of liver function tests in the patients' group are summarized in Table  1 .
There were no significant differences in serum concentrations of T4, T3, rT3, and TBG, values of T3U, FT4I, and FT3I, and ratios of T4/TBG, T3/TBG, T3/T4, rT3/T4 and rT3/T3 between the patients with CH-B and the patients with CH-NANB, nor concentrations were not significantly different between the patients group and normal subjects. Serum TBG concentrations were significantly higher in chronic liver diseases than in normal subjects, and those in LC were definitely low compared with those in CH. In LC and HCC, FT4I and FT3I values, and serum T4/TBG and T3/TBG ratios were much lower than in normal subjects. Moreover, FT3I and serum T3/TBG ratios in HCC were much lower than in LC. While serum T4/TBG and T3/TBG ratios in CH were much lower than in normal subjects, FT4I and FT3I values in CH did not differ significantly from those in normal subjects.
Serum FT4 values were significantly lower in CH and LC than in normal subjects, but not in HCC. In LC and HCC, serum FT3 values were significantly lower than in normal subjects.
However, no difference was found between CH and normal subjects. Moreover, HCC had much lower FT3 than in LC. The correlation between serum Alb. concentrations and serum FT4 or FT3 was investigated in CH, LC and HCC. Serum Alb. concentrations were noticeably and positively (n=63, r= 0.795, p<0.001) correlated with serum FT3 in these patients, but not with serum FT4. Serum FT3, however, was decreased by as much as -23.7%
in LC and by -48.9%in HCC compared with normal subjects, whereas the serum Alb. concentrations were decreased by only 12.9% in LC and by subjects.
Since some discrepancies were observed in serum FT4 and FT4I values or serum T4/TBG ratios in HCC and in serum FT3 and serum T3/TBG ratios in CH, the correlation between serum FT4 and T4/TBG ratios and between serum FT3 and T3/TBG ratios was studied. As shown in Fig. 1 ., there was a noticeable (p<0.001) and positive correlation between serum FT4 and T4/ TBG ratios in both CH and LC and normal subjects. The regression line was expressed as T4/TBG=2.239[FT4]+0.301 (n=86, r= 0.672). However, no significant correlation between them was found in HCC, and the co-ordinates between them in HCC showed a tendency to be plotted beneath the re- The regression line of CH was shifted to the right, and its slope was more gentle than that of LC, HCC, and normal subjects. Since high normal serum FT3 and low serum FT4 were observed in CH, the correlation of serum TSH concentrations with serum FT4 and FT3 was investigated, but there were no significant correlation between them.
In order to clarify the peripheral conversion of T4 to T3 or rT3, serum T3/T4, rT3/T4, and rT3/T3 ratios in the patients' group were compared with those in normal subjects. As shown in Table 2 ., there were no significant differences in these parameters between CH and normal subjects. However, serum T3/T4 ratios were much higher in LC and were much lower in HCC than in normal subjects. Serum rT3/T4 and rT3/T3 ratios were much higher in both LC and HCC than in CH and normal subjects. Moreover, serum rT3/T3 ratios in HCC were much higher than in LC. As shown in Table 3 ., serum rT3/T3 ratios in the CH and LC groups correlated significantly and positively with serum T. Bil., GOT, TTT concentrations, BSP (45') and prothrombin time, and inversely with serum T. Chol., ChE, T. Prot., and Alb.. Serum FT3 in LC In the present study, the increases in serum total T4, T3 and rT3, and decreases in T3U were found in patients with CH, as in previous reports (Iwasaki et al., 1981; Klachko and Johnson, 1983) . These increases in serum thyroid hormones were thought to be due to increased serum TBG, because the FT4I in CH did not differ from that in normal subjects. Regarding serum FT4 in CH, there were various findings indicating that these might be low because of the association with autoimmune thyroid disease (Schussler et al., 1978) , or be high because of the existence of a binding inhibitor (Borzio et al., 1983; Chopra et al., 1979a) . Although we did not measure antithyroid microsomal antibodies, our patients with CH did not have the thyroid diseases that caused hypothyroidism as reported by Schussler et al.(1978) because their serum TSH remained in the normal range and their serum rT3 was increased in spite of the normal rT3/T3 ratio. Because, in CH, both the serum T4/TBG ratios and FT4 were significantly decreased and there was a significant correlation between them and the regression was expressed in the as same way as that of normal subjects, serum FT4 was considered to be truly decreased and there was unlikely to be an inhibitor of T4 binding to TBG in CH. Since the serum T3/T4, rT3/T4 and rT3/T3 ratios in CH were normal, the thyroid hormone metabolism in CH seemed to be regarded as almost the same as that in normal subjects. For these reasons, the decrease in serum FT4 in CH was thought to be due to the moderate deficiency of serum thyroxine. The reason for the deficiency of serum thyroxine without elevated TSH in CH may be explained by illness or medication related inhibition of TSH secretion, as reported by Gooch et al.(1982) . The following two findings in the present study, that, despite the lower T3/TBG ratios, serum FT3 in CH did not differ significantly from that in normal subjects, and that the regression coefficient of serum FT3 with serum T3/TBG ratios in CH group was smaller than in the LC, HCC and normal subject groups, supported the theory of the change in binding affinity of TBG with T3. In addition, we found that there was no difference in thyroid function between CH-B and CH-NANB, or between CAH and CIH.
Although it has been reported that patients with compensated liver cirrhosis had increased T4 (Iwasaki et al., 1981; Yamanaka et al., 1980) , normal (Iwasaki et al., 1981) or increased T3 (Yamanaka et al., 1980) , and normal rT3 (Iwasaki et al., 1981; Yamanaka et al., 1980) , the present study showed decreased serum T4 and normal serum T3 and rT3 in LC despite the decrease in T3U and the increase in serum TBG as previously reported (Iwasaki et al., 1981 , Iwasaki et al., 1981 Yamanaka et al., 1980, respectively) . Consequently FT4I, FT3I, and serum T4/TBG and T3/TBG ratios in LC were decreased. The differences in serum thyroid hormones in LC from those in Iwasaki et al.(1981) and Yamanaka et al. (1980) are the evident decrease in T4 and the slight decrease in T3 in our patients with LC. These decreases in T4 and T3 in LC seemed to account for the lower FT4I, FT3I, serum T4/TBG and T3/TBG ratios in our patients with LC than in those reported by Iwasaki et al.(1981) and Yamanaka et al. (1980) . These decreases in T4 and T3 in LC were thought to be due to a lesser increase in the TBG concentration and a little more severe hepatic dysfunction, which was indicated by T. Prot., Alb., prothrombin time and ICG, in our patients with LC than in those reported by Iwasaki et al. (1981) and Yamanaka et al.(1980) .
As increased serum FT4 was often seen in decompensated liver cirrhosis instead of decreased FT4I (Borzio et al., 1983; Chopra et al., 1979a) , this was thought to be an inhibitor of binding (Chopra et al., 1979a, b; Woeber and Maddux, 1981) . However, in our present study it was thought that serum FT4 was decreased in LC, because there was observed a decrease in serum FT4 and the T4/TBG ratio in addition to decreased FT4I in LC and there was a significant correlation between FT4 and the T4/TBG ratio in LC, the regression line of which was similar to that of normal subjects. Consequently there did not seem to be an inhibitor of T4 binding to TBG in LC.
Concerning the serum T3/T4 ratio, since many factors, such as the production rates of thyroid hormones from the thyroid gland , the peripheral conversion of T4 to T3 , and the elimination rates of thyroid hormones , affect this ratio, the ratio is difficult to interpret. However, the much higher T3/T4 ratio in LC than in normal subjects seemed to imply that organisms in LC helped to maintain the serum T3 concentration when there was decreased serum T4 even if details of the mechanisms could not be explained . In our previous studies, the serum T3/T4 ratio was negatively and the serum rT3/T4 ratio was positively correlated with serum thyroid hormones and FT4I in normal subjects and hypothyroid patients (Shimada, 1984) . Pittman (1979) reported that the body concentration of T4 appeared to be a major influence modulating the conversion of T4 to T3, and that a decrease in the T4 concentration led to an increase in the conversion rate and therefore the T3 production remained stable over a wide range of T4 concentrations.
Erfurth and Hedner (1986) also reported the ability of the organism to maintain its normal serum T3 level in a situation with divergent serum T4 concentrations, for example when the serum T3/T4 ratio was increased in subclinical hypothyroidism.
For these reasons, in LC, in which serum T4, FT4, FT4I and T4/TBG ratios were low, compensating mechanisms increasing serum T3 against the reduced serum T4 appeared to operate, resulting in the high T3/T4 ratio in LC. Even if the scale was smaller than that in LC, the same phenomenon might operate in CH, in which serum T4/TBG ratios and FT4 were low and serum T3/T4 ratios showed a tendency to increase. On the other hand, a significantly high rT3/T4 ratio in LC compared with that in normal subjects supported the theory of reduced degradation of rT3 due to the decreased activity of 5'-monodeiodinase, reported by Faber et al. (1981) .
Therefore, a significantly high rT3/T3 ratio in LC indicated that the decreased activity of 5'-monodeiodinase operated more predominantly in LC than the compensating mechanisms which maintained normal serum T3. Chopra et al.(1974 Chopra et al.( , 1975 and Nomura et al.(1975) reported that serum free T4 was increased and impairment of T4 conversion might lead to reduced T3 production and decreased serum T3 in patients with decompensated liver cirrhosis. Although the thyroid functions in decompensated liver cirrhosis were not studied in the present series of experiments, the evident decrease in serum T3 appearing in decompensated liver cirrhosis may be attributed not only to impairment of the conversion of T4 to T3 but also to the release of the compensating mechanisms increasing serum T3 against the reduced serum T4. And the release of the compensating mechanisms is thought to be due to both a defense reaction protecting sick tissues from excessive metabolic stimulation and the increase in serum free T4.
The decreases in serum T4, FT4, the T4/ TBG ratio and FT4I in LC were thought to be due to serum thyroxine deficiency. This was confirmed by previous findings that there was a moderate reduction in T4 secretion by the thyroid gland (Kabadi and Premachandra, 1983; Kaptein et al., 1982) and anomalous TSH responses to thyrotropinreleasing hormone in LC (Green et al,, 1976; Hasselbalch et al., 1981) .
In accordance with the decreases in their FT3I and serum T3/TBG ratios, serum FT3 were significantly decreased in LC, and there was a significant and positive correlation between serum FT3 and T3/TBG ratio in LC, the regression line of which was similar to that of normal subjects. Therefore, it seemed unlikely that an inhibitor (Chopra et al., 1979a, b) of T3 binding to TBG or a change in the binding affinity of TBG with T3 existed in LC. The decrease in serum FT3 in LC was thought to be the outcome mainly of a deficiency of substrate, FT4. It was inferred that in LC serum T3 was decreased as well as FT3, since serum T3 derived from serum T4 and serum T4 was decreased in our patients with LC. Serum T3, however, was not decreased in LC in our present study. More detailed studies of the discrepancy between the decreased FT3 and the normal T3 in LC are needed.
Only a few reports (Gershengorn et al., 1976; Kalk et al., 1982) about the thyroid functions in HCC have appeared. In the present study, serum T4 in HCC was not increased despite the decrease in T3U and the increase in the serum TBG concentration, resulting in significantly decreased FT4I and serum T4/TBG ratio. On the other hand, serum FT4 did not differ appreciably from that in normal subjects. Therefore, these discrepancies in the serum FT4 concentration, serum T4/TBG ratio and FT4I in HCC were considered to be due to the existence of an inhibitor (Chopra et al., 1979a, b) of T4 binding to TBG or to changes in the binding affinity of TBG with T4 (Kalk et al., 1982) . Our finding that a majority of co-ordinates between FT4 and T4/TBG ratios in HCC had a tendency to be plotted beneath the regression line in the CH, LC and normal subject groups might be supported by the evidence mentioned above. However, since Inada and Sterling (1967) reported that all patients with LC exhibited a diminution in thyroxine-binding prealbumin (TBPA) capacity, the possibility that the discrepancy was due to the decrease in TBPA could not be completely ruled out. Patients with HCC in the present study exhibited the so-called low T3 syndromes. These abnormal states were brought about from severely impaired conversion of T4 to T3 because of the existence of malignancy and the severe liver cell damage. However , it seemed likely that the presence of malignancy rather than the liver dysfunction was the main cause of extraordinarily impaired conversion of T4 to T3 in HCC, because more severe liver dysfunctions were not observed in HCC than in LC. Since only 3 (19 percent) of 16 patients with HCC had increased serum TBG and no correlation between serum TBG and AFP , serum TBG could not be used as a tumor marker for HCC, as Gershengorn et al . (1976) suggested.
In CH and LC, the serum rT3/T3 ratio was significantly correlated with various liver function tests. In addition, in LC and HCC it was seen that serum FT3 was related significantly to BSP (45') and KICG . These findings suggested that the more severe the liver damage became, the more the conversion of T4 to T3 was inhibited in chronic liver disease. Our findings were thought to raise a new possibility in regard to the conversion of T4 to T3 in chronic liver disease beside the previous reports (Kabadi and Premachandra, 1983; Yamanaka et al., 1980) that the marked changes in peripheral conversion of T4 to T3 were found only in decompensated liver cirrhosis among the various liver diseases. Zaninovich et al.(1971) reported that the serum TBG level in liver cirrhosis was within normal limits because of an increase in TBG capacity due to the hyperoestrogenic syndrome and a decreased in TBG synthesis due to the hepatic dysfunction. We found that serum TBG in CH and LC was higher than in normal subjects and serum TBG was significantly and positively correlated with the serum transaminase concentration and inversely with prothrombin time, but not with BSP (45') or KICG. As Gardner et al.(1982) reported, the mechanism of the rise in serum TBG in patients with acute hepatitis B virus infection (a discharge of TBG from the injured hepatic cells, like that of transaminase from the diseased liver) was thought to participate in one of the mechanisms of elevated serum TBG in these patients in addition to the mechanism reported by Zaninovich et al.(1971) . Amino et al.(1983) reported that the serum Alb. concentration influenced the assay of serum FT4 with the Amerlex Free T4 RIA kit. The significant and positive correlation between the serum Alb. concentration and FT3 in CH, LC and HCC partially accounted for the decreased FT3 in LC and HCC, in which serum Alb. was decreased. In LC and HCC the decrease in FT3, however, was much greater than the decrease in the serum Alb. concentration, therefore decreased FT3 in LC and HCC were thought to be influenced not only by decreased serum Alb. but also by hepatic dysfunctions. Serum FT4 might be influenced by the serum Alb. concentration in LC and HCC though there was no correlation between serum Alb. and FT4.
Although Borzio et al.(1983) suggested that the euthyroid state in these patients was maintained probably by low normal FT3 and high normal FT4, we found decreased FT4 and FT3 in chronic liver diseases, except for FT4 in HCC and FT3 in CH. Concerning the thyroid functions in nonthyroidal illness, there have been reported the existence of mild pituitary suppression (Kaptein et al., 1981) and thyroid hormone deficiency (Bacci et al., 1982) ; but the replacement therapy has been regarded as unnessesary for reasons such as the increase in rT3 and T4 (Chopra et al., 1979a) , the lack of overt free T4 deficiency (Kaptein et al., 1981) and the adaptation to a decrease in caloric demand (Bacci et al., 1982) . In our present study it also remains an unsolved problem whether the various changes in thyroid hormones in chronic liver diseases mean a beneficial response to the sick organism or indicate subclinical hypothyroidism. Further studies should be necessary to determine whether the thyroid functions in chronic liver diseases are truly euthyroid or not, and whether patients with chronic liver diseases require T4 replacement therapy or not.
Concerning the thyroid functions in chronic liver diseases, it is concluded that (1) a moderate serum thyroxine deficiency exists in CH, although serum T4, T3 and rT3 are increased due to the increase in TBG;(2) a deficiency of serum thyroxine and compensating mechanisms which maintain the normal serum T3 concentration exist in LC;(3) in CH, LC and HCC, serum TBG is increased and the degree of increase in TBG is in proportion to that of the liver cell damage; and (4) the degree of impairment of the conversion of T4 to T3 is in proportion to that of the hepatic dysfunction in CH, LC and HCC.
